What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity? [electronic resource]
Producer: 20101103Description: 480-1 p. digitalISSN:- 1533-712X
- Antipsychotic Agents -- adverse effects
- Aripiprazole
- Benzodiazepines -- adverse effects
- Controlled Clinical Trials as Topic
- Double-Blind Method
- Humans
- Obesity -- chemically induced
- Olanzapine
- Piperazines -- pharmacology
- Quinolones -- pharmacology
- Schizophrenia -- drug therapy
- Weight Gain -- drug effects
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment
There are no comments on this title.
Log in to your account to post a comment.